Ranibizumab found effective against diabetic retinopathy

v

Public Release: 17-Nov-2015
Ranibizumab found effective against diabetic retinopathy
Study results show it's a good alternative to laser therapy, and with fewer side effects
Johns Hopkins Medicine

In a randomized clinical trial of more than 300 participants, researchers from Johns Hopkins and elsewhere have found that ranibizumab -- a drug most commonly used to treat retinal swelling in people with diabetes -- is an effective alternative to laser therapy for treating the most severe, potentially blinding form of diabetic retinal disease. Results of the government-sponsored study also show that the drug therapy carries fewer side effects than the currently used laser treatment.

•••••